David Bailey
Stock Analyst at Morgan Stanley
(4.11)
# 1,614
Out of 5,032 analysts
228
Total ratings
52.9%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: COH Cochlear Limited | Reiterated: Hold | $133.00 | $129.50 | +2.70% | 18 | Oct 1, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $23.90 | $15.87 | +50.60% | 18 | Sep 15, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.70 | $2.14 | +72.90% | 7 | Sep 8, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Hold | n/a | $31.90 | - | 31 | Sep 7, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Sell | $40.90 → $41.90 | $54.55 | -23.19% | 38 | Sep 3, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $172.00 → $182.00 | $181.99 | +0.01% | 33 | Sep 2, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Sell | $20.60 → $20.30 | $18.83 | +7.81% | 21 | Sep 1, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $32.70 → $37.90 | $45.50 | -16.70% | 17 | Aug 31, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | n/a | $47.00 | - | 11 | Aug 24, 2026 | |
| RMD ResMed | Reiterated: Hold | $230 | $220.69 | +4.22% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $127.50 → $152.50 | $159.91 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.50 → $1.35 | $0.41 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.05 → $3.55 | $4.35 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.05 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.36 | $2.83 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $0.90 | n/a | 1 | Jan 21, 2021 |
Cochlear Limited
Oct 1, 2026
Reiterated: Hold
Price Target: $133.00
Current: $129.50
Upside: +2.70%
Telix Pharmaceuticals Limited
Sep 15, 2026
Reiterated: Buy
Price Target: $23.90
Current: $15.87
Upside: +50.60%
Integral Diagnostics Limited
Sep 8, 2026
Reiterated: Buy
Price Target: $3.70
Current: $2.14
Upside: +72.90%
ResMed Inc.
Sep 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $31.90
Upside: -
Ramsay Health Care Limited
Sep 3, 2026
Reiterated: Sell
Price Target: $40.90 → $41.90
Current: $54.55
Upside: -23.19%
CSL Limited
Sep 2, 2026
Reiterated: Buy
Price Target: $172.00 → $182.00
Current: $181.99
Upside: +0.01%
Sonic Healthcare Limited
Sep 1, 2026
Reiterated: Sell
Price Target: $20.60 → $20.30
Current: $18.83
Upside: +7.81%
Ansell Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $32.70 → $37.90
Current: $45.50
Upside: -16.70%
Fisher & Paykel Healthcare Corporation Limited
Aug 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $47.00
Upside: -
ResMed
Jul 13, 2026
Reiterated: Hold
Price Target: $230
Current: $220.69
Upside: +4.22%
Aug 15, 2024
Reiterated: Buy
Price Target: $127.50 → $152.50
Current: $159.91
Upside: n/a
Feb 28, 2024
Reiterated: Hold
Price Target: $1.50 → $1.35
Current: $0.41
Upside: n/a
Jan 31, 2024
Reiterated: Buy
Price Target: $3.05 → $3.55
Current: $4.35
Upside: n/a
Aug 24, 2021
Reiterated: Hold
Price Target: n/a
Current: $13.05
Upside: n/a
Jan 21, 2021
Reiterated: Hold
Price Target: $0.36
Current: $2.83
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $0.90
Upside: n/a